Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy

Medical Mycology

Volumn 41, Issue 4, 2003, Pages 339-345

  Trinh, Jane V ^b   Steinbach, William J ^a,b   Schell, Wiley A ^a,b   Kurtzberg, Joanne ^a,b   Giles, Steven S ^a,b   Perfect, John R ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain abscess; Caspofungin; Cladophialophora; Pediatric; Voriconazole

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; CHLORAMPHENICOL; ECHINOCANDIN B; FLUCYTOSINE; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; TRIAZOLE; VORICONAZOLE;

ARTICLE; BLOOD TRANSFUSION; BRAIN ABSCESS; BRAIN HERNIA; CASE REPORT; DEATH; DISEASE COURSE; FATALITY; HEMIPARESIS; HUMAN; IMMUNE DEFICIENCY; LETHARGY; LUNG LAVAGE; LUNG MYCOSIS; MALAISE; MALE; MUSCLE WEAKNESS; NONHUMAN; PARESIS; PHAEOHYPHOMYCOSIS; PROGNOSIS; SCHOOL CHILD; UMBILICAL CORD BLOOD;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ASCOMYCOTA; BRAIN ABSCESS; BRAIN DISEASES; CHILD; DRUG THERAPY, COMBINATION; FATAL OUTCOME; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MYCOSES; PEPTIDES; PEPTIDES, CYCLIC; PYRIMIDINES; TRIAZOLES;

CLADOPHIALOPHORA; CLADOPHIALOPHORA BANTIANA;

EID: 0042825787     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/369378031000137369     Document Type: Article

References (33)

1. DeHoog GS, Guého E, Masclaux F, Van Den Ende Gerrits HG, Kwon-Chung KJ, McGinnis MR. Nutritional physiology and taxonomy of human-pathogenic Cladosporium-Xylohypha species. J Med Vet Mycol 1995; 33: 339-347.
2. Dixon DM, Walsh TJ, Merz WG, McGinnis MR. Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis 1989; 11: 515-525.
3. Heney C, Song E, Kellen A, Raal F, Miller SD, Davis V. Cerebral phaeohyphomycosis caused by Xylohypha bantiana. Eur J Clin Microbiol Infect Dis 1989; 8: 984-988.
4. Palaoglu S, Sav A, Basak T, Yalcinlar Y, Scheithauer BW. Cerebral phaeohyphomycosis. Neurosurgery 1993; 33: 894-897.
5. Gugnani HC, Sidiqqui N, Magulike MO. Cerebral phaeohyphomycosis: Report of a case from Nigeria. Mycoses 1998; 41: 431-432.
6. Osiyemi OO, Dowdy LM, Mallon SM, Cleary T. Cerebral phaeohyphomycosis due to a novel species: Report of a case and review of the literature. Transplantation 2001; 71: 1343-1346.
7. Horré R, De Hoog GS. Primary cerebral infections by melanzied fungi: A review. Stud Mycol 1999; 43: 176-193.
8. Schell WA. Dematiaceous Hyphomycetes. In: Howard DH (ed.). Pathogenic Fungi in Humans and Animals, 2nd edn. New York: Marcel-Dekker, 2003: 565-636.
9. Gerrits Van Den Ende AHG, De Hoog GS. Variability and molecular diagnostics of the neurotropic species Cladophialophora bantiana. Stud Mycol 1999; 43: 151-162.
10. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming Filamentous Fungi. Proposed standard M38-P. Villanova, PA: National Committee for Clinical Laboratory Standards, 1998.
11. McGinnis MR, Lemon SM, Walker DH, De Hoog GS, Haase G. Fatal cerebritis caused by a new species of Cladophialophora. Stud Mycol 1999; 43: 166-171.
12. Banti G. Sopra un caso di oidiomicosi cerebrale, Atti Accad Medico-Fisica Fiorentina 1911; 49.
13. Banti G. Sopra un caso di oidiomicosi cerebrale. Lo Sperimentale 1911; 65: 341.
14. Banerjee U, Mohapatra AK, Sarkar C, Chaudhery R. Cladosporiosis (cerebral phaeohyphomycosis) of brain - A case report. Mycopathologia 1989; 105: 163-166.
15. Kim RC, Hodge CJ, Lamberson HV, Weiner LB. Traumatic intracerebral implantation of Cladosporium trichoides. Neurology 1981; 31: 1145-1148.
16. Bennett JE, Bonner H, Jennings AE, Lopez RI. Chronic meningitis caused by Cladosporium trichoides. Am J Clin Pathol 1973; 59: 398-407.
17. Hironaga M, Watanabe S. Cerebral phaeohyphomycosis caused by Cladosporium bantiana: A case in a female who had cutaneous alternariosis in her childhood. Sabouraudia 1980; 18: 229-235.
18. Sandhyamnai S, Bhatia R, Mohapatra N, Roy S. Cerebral cladosporiosis. Surg Neurol 1981; 15: 431-434.
19. Watson KC. Cerebral chromoblastomycosis. J Pathol Bacteriol 1962; 84: 233-237.
20. Sabo J, Abdel-Rahman S. Voriconazole: A new triazole antifungal. Ann Pharmacother 2000; 34: 1032-1043.
21. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of voriconazole (UK-109, 496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother 1997; 41: 841-843.
22. McGinnis MR, Pasarell L. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J Clin Microbiol 1998; 36: 2353-2355.
23. Wildfeuer A, Seidl HP, Paule I, Haberreiter A. In vitro evaluation of voriconazole against clinical isolates of yeast, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 1998; 41: 309-319.
24. Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001; 39: 954-958.
25. McGinnis M, Pasarell L. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med Mycol 1998; 36: 243-246.
26. Johnson E, Szekely A, Warnock D. In vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998; 42: 741-745.
27. Nesky MA, McDougal EC, Peacock JE Jr. Pseudoallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: Case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis 2000; 31: 673-677.
28. Maesaki S, Iwakawa J, Higashiyama Y, et al. Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp. J Infect Chemother 2000; 6: 101-103.
29. Denning DW, Ribaud P, Milpied N, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002; 34: 563-571.
30. Walsh TJ, Viviani MA, Arathoon E, et al. New targets and delivery systems for antifungal therapy. Med Mycol 2000; 38(Suppl. 1): 335-47.
31. Ernst E. Investigational antifungal agents. Pharmacotherapy 2001; 21: 165S-175S.
32. Keating GM, Jarvis B. Caspofungin. Drugs 2001; 61: 1121-1129.
33. Espinel-Ingroff A. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998; 36: 2950-2956.